Opus Genetics Inc (IRD) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Opus Genetics Inc   (NASDAQ: IRD)


Opus Genetics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Opus Genetics Inc's ROI in the second quarter of 2026?
Opus Genetics Inc recorded a cumulative net loss of $-115 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -239.19%.

Within the Healthcare sector 744 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 4212 to 4346.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 197.83 % 44.6 % -42.81 % -78.17 % -65.45 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 85 57 42 7 18
Return On Investment (TTM) -239.19 % -341.04 % -271.57 % -354.57 % -143.35 %
IRD's Overall Ranking # 4346 # 4212 # 3796 # 0 # 0
Seq. Investment Change TTM 53.33 % 71.7 % 95.8 % -42.23 % -25.55 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -115 -107 -50 -33 -23

IRD Company Profile >> Back to IRD Roi Comparisons >> See Annual IRD Return On Investment



Return On Investment IRD's Ranking
Within: No.
Industry # 354
Sector # 745
Overall # 4346

Return On Investment Statistics
High Average Low
79.52 %
-187.3 %
-3821.35 %
(Dec 31 2022)   (Mar 31 2021)







Financial Statements
Opus Genetics Inc's II. Quarter Investments $ 85 Millions IRD's Balance sheet
Opus Genetics Inc's II. Quarter Income $ -15 Millions Quarterly IRD's Income Statement
IRD's Income by Division See IRD's Income by Division


IRD Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 42 26 50 46 22
Y / Y Investment Growth 66.08 % -48.77 % 7.93 % 108.08 % 53.29 %
Net Income in Millions -50 -58 -10 18 -57
Y / Y Net Income Growth - - - - -
Annual Return On Investment -116.79 % -225.02 % -20.01 % 38.69 % -255.12 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IRD's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IRD's Competitors
Subscribers only: Roi for Opus Genetics Inc's Suppliers
Subscribers only: Return On Investment for IRD's Customers

Other Ratios
IRD's Roa IRD's Inventory Turnover Ratio IRD's Growth Rates IRD's Dividend Statistics
IRD's Profitability Ratios IRD's Asset Turnover Ratio IRD's Dividend Growth
IRD's Roe IRD's Valuation Ratios IRD's Financial Strength Ratios IRD's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-05T15:15:09+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.